抗生物膜伤口敷料市场（按机制模式、应用和地区划分）

抗生物膜伤口敷料市场规模预计在 2025 年为 9.456 亿美元，预计到 2032 年将达到 22.944 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 13.5%。

抗生物膜敷料产品可用于处理大面积伤口，降低感染风险。使用藻酸盐或聚合物泡棉抗菌或抑菌敷料处理伤口可防止生物膜再形成。抗生物膜剂可用于预防生物膜形成或防止清创后生物膜再形成，进而促进创伤治疗。

市场动态：

慢性病盛行率上升、慢性伤口负担加重、老年人口增加、外科手术数量增加以及对先进创伤护理产品的需求增加是预测期内推动全球抗生物膜伤口敷料市场成长的关键因素。

例如，2021年10月，Imbed Biosciences获得了美国国家关节炎、肌肉骨骼和皮肤疾病研究所（NIAMS）80万美元的创伤治疗试点（CRP）接受，以支持下一代伤口敷料的后期开发，该敷料可以杀死津贴在伤口生物膜中的细菌并促进伤口癒合。

本研究的主要特点

• 本报告对全球抗生物膜伤口敷料市场进行了详细分析，并以 2024 年为基准年，提供了 2025 年至 2032 年预测期的市场规模和年复合成长率（CAGR%）。
• 它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
• 该报告涵盖了全球抗生物膜伤口敷料市场的主要企业概况，基于以下参数，例如公司亮点、产品系列、关键亮点、财务表现和策略。
• 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
• 全球生物膜伤口敷料市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过用于分析全球抗生物膜伤口敷料市场的各种策略矩阵来简化决策。

目录

第一章 研究目的与前提

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 慢性伤口的盛行率不断上升
  • 医疗费用高昂
  • 创伤护理产品需求旺盛
• 影响分析
• 主要亮点
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景

4. 全球抗生物膜伤口敷料市场-冠状病毒（COVID-19）大流行的影响

• COVID-19流行病学
• 供需侧分析
• 经济影响

5. 2020 年至 2032 年全球抗生物膜伤口敷料市场（以机制模式）

• 身体的
• 化学
• 生物

6. 全球抗生物膜伤口敷料市场（按应用）2020 年至 2032 年

• 急性伤口
• 慢性伤口

7. 2020 年至 2032 年全球抗生物膜伤口敷料市场（按地区）

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第八章 竞争态势

• 3M
• Convatec Group PLC
• Smith & Nephew PLC
• Urgo Medical
• Coloplast Corporation

第九章 章节

• 调查方法
• 关于出版商

Anti-Biofilm Wound Dressing Market is estimated to be valued at USD 945.6 Mn in 2025 and is expected to reach USD 2,294.4 Mn by 2032, growing at a compound annual growth rate (CAGR) of 13.5% from 2025 to 2032.

Anti-biofilm dressing products help manage large wounds, thereby, reducing the risk of infection. Treating wounds with an antimicrobial or bacteriostatic dressing in an alginate or polymeric foam form will help prevent reformation of biofilms. Anti-biofilm agents can be used to prevent biofilm formation or to prevent reformation after debridement, thereby improving the wound healing.

Market Dynamics:

Increasing incidence of chronic diseases, increasing burden of chronic wounds, growing geriatric population, increasing number of surgical procedures, and high demand for advanced wound care products are major factors expected to propel the growth of the global anti-biofilm wound dressing market during the forecast period.

For instance, in October 2021, Imbed Biosciences received US$ 800,000 in a Commercialization Readiness Pilot (CRP) grant from the National Institute for Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to support late-stage development of a next-generation wound dressing that can kill bacteria hidden inside the biofilms in wounds and accelerate wound healing.

Key features of the study:

• This report provides in-depth analysis of the global anti-biofilm wound dressing market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global anti-biofilm wound dressing market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include 3M, Convatec Group PLC, Smith & Nephew PLC, Urgo Medical, and Coloplast Corporation, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global anti-biofilm wound dressing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-biofilm wound dressing market.

Detailed Segmentation:

• Global Anti-Biofilm Wound Dressing Market, By Mode of Mechanism:
  • Physical
  • Chemical
  • Biological
• Global Anti-Biofilm Wound Dressing Market, By Application:
  • Acute Wounds
  • Chronic Wounds
• Global Anti-Biofilm Wound Dressing Market, By Geography:
  • North America
  • Latin America Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
  • 3M
  • Convatec Group PLC
  • Smith & Nephew PLC
  • Urgo Medical
  • Coloplast Corporation

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Mode of Mechanism
  • Market Snapshot, By Application
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing prevalence of chronic wounds
  • High cost of treatment
  • High demand for wound care products
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Anti-Biofilm Wound Dressing Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Anti-Biofilm Wound Dressing Market, By Mode of Mechanism, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Physical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Chemical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Biological
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Anti-Biofilm Wound Dressing Market, By Application, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Acute Wounds
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Chronic Wounds
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Anti-Biofilm Wound Dressing Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Mechanism, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Mechanism, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Mechanism, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Mechanism, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Mechanism, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Mechanism, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)

8. Competitive Landscape

• 3M
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Convatec Group PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Smith & Nephew PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Urgo Medical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Coloplast Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us